In Silico investigation of echinodermata secondary metabolites as human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors

Research output: Contribution to journalArticle

Abstract

Objective: Human immunodeficiency virus (HIV) targets the immune system and weakens immune surveillance and defenses against infections, leading to acute immunodeficiency syndrome. Recent trends in drug discovery from natural sources emphasize investigations of compounds from marine ecosystems. Methods: In this study, we compiled a database of chemical compounds from echinoderms and virtually screened for those that inhibit HIV-1 reverse transcriptase (RT). The database was generated from literature searches. Virtual screening analyses for inhibitors of HIV-1 RT were then performed using AutoDock software. Results: Based on screening results, the top thirteen ranked compounds were nobilisidenol B, Ech_005, 17-deoxyholothurinogenin, 22,25-oxidoholothurinogenin, Ech_022, Ech_026, Ech_021, nobilisidenol A, Ech_025, 5α-cholest-8(14)-ene-3β,7α-diol, astropecten A, Ech_004, and phrygiasterol. Conclusion: The present in silico screening analyses of compounds from marine ecosystems can be used to identify candidate compounds with high potential as drugs for the treatment of refractory HIV infections.

Original languageEnglish
Pages (from-to)51-55
Number of pages5
JournalInternational Journal of Applied Pharmaceutics
Volume12
Issue numberSpecial Issue 1
DOIs
Publication statusPublished - Mar 2020

Keywords

  • Echinoderms
  • Human immunodeficiency virus
  • Reverse transcriptase inhibitor

Fingerprint Dive into the research topics of 'In Silico investigation of echinodermata secondary metabolites as human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors'. Together they form a unique fingerprint.

  • Cite this